Osteoporosis in postmenopausal women: pathogenetic relationships with coronary heart disease and obesity (literature review)
DOI:
https://doi.org/10.14739/2310-1237.2025.2.332421Keywords:
osteoporosis, coronary heart disease, obesity, menopause, relationshipAbstract
Aim: to summarize and analysis of current literature data on the pathophysiological mechanisms of the relationship between osteoporosis, coronary heart disease and obesity in postmenopausal women.
Materials and methods. A systematic analysis of scientific publications presented in the databases PubMed, Scopus, Web of Science, Google Scholar, as well as in national medical information resources of Ukraine was conducted. The work included scientific articles that met the inclusion criteria for the topic, completeness of the text, and relevance.
Results. Osteoporosis, coronary heart disease, and obesity are the three most common diseases among postmenopausal women, which have a high level of medical and social significance due to their chronic course, high incidence of complications, and impact on functional capacity and quality of life. Estrogen deficiency in postmenopausal women is a key trigger for pathological changes in bone, metabolic, and vascular homeostasis.
Recent studies demonstrate the presence of common pathogenetic links for these conditions, such as chronic low-level inflammation, endothelial dysfunction, estrogen deficiency, insulin resistance, lipid metabolism disorders, and adipokines imbalance. Decreased bone mineral density (BMD) correlates with atherosclerotic vascular lesions, and vascular calcification is often accompanied by bone loss. Osteotropic proteins are also found in vascular walls, indicating a biological transition between bone and vascular tissues. Low BMD is associated with an increased risk of cardiovascular mortality, especially in the elderly.
Obesity also has a systemic negative impact on bone and cardiovascular health through activation of pro-inflammatory cytokines and stimulation of bone resorption. However, the current literature contains conflicting data on the impact of obesity on BMD: moderate excess body weight may have a protective effect on BMD loss, but obesity of II–III degree is significantly associated with an increased risk of osteoporotic fractures. This necessitates the need for risk stratification taking into account the degree of obesity and concomitant cardio-metabolic pathology.
Conclusions. The presence of common pathogenetic mechanisms of osteoporosis, coronary heart disease, and obesity confirms the feasibility of developing comprehensive approaches to the prevention, early diagnosis, and treatment of these conditions in postmenopausal women.
References
Azeez TA. Osteoporosis and cardiovascular disease: a review. Mol Biol Rep. 2023;50(2):1753-63. doi: https://doi.org/10.1007/s11033-022-08088-4
Tsymbaliuk T, Krylova A, Dubkova A. [Features of the Course and Treatment of Osteoarthritis in Patients with Osteoporosis and Obesity]. Family medicine. European practices. 2021;(1):25-31. Ukrainian. doi: https://doi.org/10.30841/2307-5112.1.2021.231925
Khandkar C, Vaidya K, Karimi Galougahi K, Patel S. Low bone mineral density and coronary artery disease: A systematic review and meta-analysis. Int J Cardiol Heart Vasc. 2021;37:100891. doi: https://doi.org/10.1016/j.ijcha.2021.100891
Arjunan D, Prasad TN, Das L, Bhadada SK. Osteoporosis and obesity. Indian J Orthop. 2023;57(Suppl 1):218-24. doi: https://doi.org/10.1007/s43465-023-01052-9
Qiao D, Li Y, Liu X, Zhang X, Qian X, Zhang H, et al. Association of obesity with bone mineral density and osteoporosis in adults: a systematic review and meta-analysis. Public Health. 2020;180:22-8. doi: https://doi.org/10.1016/j.puhe.2019.11.001
Povoroznyuk V, Grygorieva N, Johansson H, Lorentzon M, Harvey NC, McCloskey EV, et al. FRAX-Based Intervention Thresholds for Osteoporosis Treatment in Ukraine. J Osteoporos. 2021;2021:2043479. doi: https://doi.org/10.1155/2021/2043479
Litovka IG. [Effect of obesity on bone metabolism]. Fiziolohichnyi zhurnal. 2021;67(2):67-75. Ukrainian. doi: https://doi.org/10.15407/fz67.02.067
Clynes MA, Harvey NC, Curtis EM, Fuggle NR, Dennison EM, Cooper C. The epidemiology of osteoporosis. Br Med Bull. 2020;133(1):105-17. doi: https://doi.org/10.1093/bmb/ldaa005
Gao Y, Patil S, Jia J. The Development of Molecular Biology of Osteoporosis. Int J Mol Sci. 2021;22(15):8182. doi: https://doi.org/10.3390/ijms22158182
Pylypchuk IS, Pylypchuk II. Osteoporoz ta yakist zhyttia zhinky u XXI stolitti [Osteoporosis and the quality of life of women in the XXI century]. In: Challenges and achievements of medical science and education. Izdevnieciba "Baltija Publishing"; 2020. p. 253-75. Ukrainian. doi: https://doi.org/10.30525/978-9934-26-024-7-13
Walker MD, Shane E. Postmenopausal osteoporosis. N Engl J Med. 2023;389(21):1979-91. doi: https://doi.org/10.1056/nejmcp2307353
Uddenberg ER, Safwan N, Saadedine M, Hurtado MD, Faubion SS, Shufelt CL. Menopause transition and cardiovascular disease risk. Maturitas. 2024;185:107974. doi: https://doi.org/10.1016/j.maturitas.2024.107974
Aibar-Almazán A, Voltes-Martínez A, Castellote-Caballero Y, Afanador-Restrepo DF, Carcelén-Fraile MD, López-Ruiz E. Current Status of the Diagnosis and Management of Osteoporosis. Int J Mol Sci. 2022;23(16):9465. doi: https://doi.org/10.3390/ijms23169465
Rozenberg S, Bruyère O, Bergmann P, Cavalier E, Gielen E, Goemaere S, et al. How to manage osteoporosis before the age of 50. Maturitas. 2020;138:14-25. doi: https://doi.org/10.1016/j.maturitas.2020.05.004
Schini M, Johansson H, Harvey NC, Lorentzon M, Kanis JA, McCloskey EV. An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis. J Endocrinol Invest. 2024;47(3):501-11. doi: https://doi.org/10.1007/s40618-023-02219-9
Syu DK, Hsu SH, Yeh PC, Kuo YF, Huang YC, et al. The association between coronary artery disease and osteoporosis: a population-based longitudinal study in Taiwan. Arch Osteoporos. 2022;17(1):91. doi: https://doi.org/10.1007/s11657-022-01128-3
Liu X, Chen F, Liu L, Zhang Q. Prevalence of osteoporosis in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies. BMC Endocr Disord. 2023;23(1):1. doi: https://doi.org/10.1186/s12902-022-01260-8
Honigberg MC, Zekavat SM, Niroula A, Griffin GK, Bick AG, Pirruccello JP, et al. Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women. Circulation. 2021;143(5):410-23. doi: https://doi.org/10.1161/CIRCULATIONAHA.120.051775
Chuang TL, Chuang MH, Koo M, Lin CH, Wang YF. Association of bone mineral density and trabecular bone score with cardiovascular disease. Tzu Chi Med J. 2020;32(3):234-9. doi: https://doi.org/10.4103/tcmj.tcmj_234_19
Stein PK, Buzkova P, Fink HA, Robbins JA, Mukamal KJ, Cauley JA, et al. Cardiovascular autonomic nervous system function and hip fracture risk: the Cardiovascular Health Study. Arch Osteoporos. 2021;16(1):163. doi: https://doi.org/10.1007/s11657-021-01028-y
Värri M, Niskanen L, Tuomainen TP, Honkanen R, Kröger H, Tuppurainen MT. Metabolite Profiling of Osteoporosis and Atherosclerosis in Postmenopausal Women: A Cross-Sectional Study. Vasc Health Risk Manag. 2020;16:515-24. doi: https://doi.org/10.2147/VHRM.S279028
Mishra BH, Mishra PP, Raitoharju E, Marttila S, Mononen N, Sievänen H, et al. Modular genome-wide gene expression architecture shared by early traits of osteoporosis and atherosclerosis in the Young Finns Study. Sci Rep. 2021;11(1):7111. doi: https://doi.org/10.1038/s41598-021-86536-0
Zhang J, Hu W, Zou Z, Li Y, Kang F, Li J, et al. The role of lipid metabolism in osteoporosis: Clinical implication and cellular mechanism. Genes Dis. 2023;11(4):101122. doi: https://doi.org/10.1016/j.gendis.2023.101122
Martini N, Streckwall L, McCarthy AD. Osteoporosis and vascular calcifications. Endocr Connect. 2023;12(11):e230305. doi: https://doi.org/10.1530/EC-23-0305
Singh P, Singh M, Khinda R, Valecha S, Kumar N, Singh S, et al. Genetic Scores of eNOS, ACE and VEGFA Genes Are Predictive of Endothelial Dysfunction Associated Osteoporosis in Postmenopausal Women. Int J Environ Res Public Health. 2021;18(3):972. doi: https://doi.org/10.3390/ijerph18030972
Seeto AH, Tadrous M, Gebre AK, Lewis JR, Fink HA, Ebeling PR, et al. Evidence for the cardiovascular effects of osteoporosis treatments in randomized trials of post-menopausal women: A systematic review and Bayesian network meta-analysis. Bone. 2023;167:116610. doi: https://doi.org/10.1016/j.bone.2022.116610
Chi G, Qiu L, Ma J, Wu W, Zhang Y. The association of osteoprotegerin and RANKL with osteoporosis: a systematic review with meta-analysis. J Orthop Surg Res. 2023;18(1):839. doi: https://doi.org/10.1186/s13018-023-04179-5
Huang X, Ni B, Li Q, Liu M, Zhao M, Zhang Y, et al. Association between Postmenopausal Osteoporosis and IL-6、TNF-α: A Systematic Review and A Meta-analysis. Comb Chem High Throughput Screen. 2024;27(15):2260-6. doi: https://doi.org/10.2174/0113862073262645231121025911
Mun H, Liu B, Pham TH, Wu Q. C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches. Osteoporos Int. 2021;32(3):425-35. doi: https://doi.org/10.1007/s00198-020-05623-6
Liu Y, Liu Y, Huang Y, Le S, Jiang H, Ruan B, et al. The effect of overweight or obesity on osteoporosis: A systematic review and meta-analysis. Clin Nutr. 2023;42(12):2457-67. doi: https://doi.org/10.1016/j.clnu.2023.10.013
Sørensen TI, Martinez AR, Jørgensen TS. Epidemiology of obesity. In: Eckel J, Clément K, editors. From Obesity to Diabetes. Handbook of Experimental Pharmacology. Vol 274. Springer, Cham; 2022. p. 3-27. doi: https://doi.org/10.1007/164_2022_581
Kalmykova YS. [Prevalence of obesity and metabolic syndrome in young people: current state of the problem]. Rehabilitation and Recreation. 2023;(14):49-55. Ukrainian. https://doi.org/10.32782/2522-1795.2023.14.5
Mykhailovska NS, Stetsiuk IO. [Clinical efficiency of combined pharmacotherapy of сoronary artery disease associated with postmenopausal osteoporosis]. Bukovinian medical herald. 2020;24(4):65-74. Ukrainian. doi: https://doi.org/10.24061/2413-0737.xxiv.4.96.2020.104
Mohammad Rahimi GR, Bijeh N, Rashidlamir A. Effects of exercise training on serum preptin, undercarboxylated osteocalcin and high molecular weight adiponectin in adults with metabolic syndrome. Exp Physiol. 2020;105(3):449-59. doi: https://doi.org/10.1113/EP088036
Greere DI, Grigorescu F, Manda D, Lautier C, Poianã C. Insulin resistance and postmenopausal osteoporosis. Acta Endocrinol (Buchar). 2023;19(3):349-63. doi: https://doi.org/10.4183/aeb.2023.349
Mohammadi SM, Saniee N, Borzoo T, Radmanesh E. Osteoporosis and Leptin: A Systematic Review. Iran J Public Health. 2024;53(1):93-103. doi: https://doi.org/10.18502/ijph.v53i1.14686
Palacios S, Chedraui P, Sánchez-Borrego R, Coronado P, Nappi RE. Obesity and menopause. Gynecol Endocrinol. 2024;40(1):2312885. doi: https://doi.org/10.1080/09513590.2024.2312885
Greere D, Grigorescu F, Manda D, Voicu G, Lautier C, Nitu I, et al. Relative Contribution of Metabolic Syndrome Components in Relation to Obesity and Insulin Resistance in Postmenopausal Osteoporosis. J Clin Med. 2024;13(9):2529. doi: https://doi.org/10.3390/jcm13092529
Grygorieva N, Kovalenko V, Коrzh М, Tatarchuk T, Dedukh N, Strafun S, et al. [Guideline for diagnostic, prevention and treatment of postmenopausal osteoporosis]. Pain, Joints, Spine. 2023;13(3):128-54. Ukrainian. doi: https://doi.org/10.22141/pjs.13.3.2023.378
Cheng CH, Chen LR, Chen KH. Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover. Int J Mol Sci. 2022;23(3):1376. doi: https://doi.org/10.3390/ijms23031376
Xiang D, Liu Y, Zhou S, Zhou E, Wang Y. Protective Effects of Estrogen on Cardiovascular Disease Mediated by Oxidative Stress. Oxid Med Cell Longev. 2021;2021:5523516. doi: https://doi.org/10.1155/2021/5523516
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 N. S. Mykhailovska, I. O. Stetsiuk, S. M. Manuilov, Ya. M. Mykhailovskyi, O. O. Lisova, O. V. Shershnova
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
